Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
JK Biostatistics AB
AB
Active
Org 5567666473
Karlbergsvägen 74, 113 35
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2008 · 17 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
JK Biostatistics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2020: 3M
3M
2020
2021: 3M (0% vs 2020)
3M
0%
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 3M (0% vs 2022)
3M
0%
2023
2024: 2M (-33% vs 2023)
2M
-33%
2024
EBITDA
SEK millions
1M
1M
1M
0M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
2 140
2 845
2 966
2 661
2 522
Staff expenses
−1 137
−1 388
−1 188
—
—
EBITDA
30
185
549
685
841
Depreciation & amort.
−17
−32
—
−0
−0
EBIT
13
154
549
685
841
Net financials
−8
−1
−3
57
−1
Profit before tax
5
153
546
742
841
Tax
−35
−49
−217
−153
−195
Net profit
−30
104
329
589
646
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
1 834
2 127
1 531
1 451
1 400
Equity
1 350
1 380
1 276
1 112
773
Long-term debt
—
—
—
0
0
Short-term debt
484
747
255
339
627
Total debt
484
747
255
339
627
Financial ratios
5-year trend
EBITDA margin
1,4 %
This company
15,8 %
Market median
This company
Market median
91% below market
2020
2024
Equity ratio
73,6 %
This company
38,2 %
Market median
This company
Market median
93% above market
2020
2024
Return on equity
−2,2 %
This company
18,4 %
Market median
This company
Market median
112% below market
2020
2024
Net profit margin
−1,4 %
This company
8,1 %
Market median
This company
Market median
117% below market
2020
2024
Asset turnover
1,17×
This company
1,12×
Market median
This company
Market median
4% above market
2020
2024
Debt / equity
0,36×
This company
0,62×
Market median
This company
Market median
42% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on JK Biostatistics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
